web analytics
CBD

FDA approves GW Pharmaceuticals’ cannabis drug for new indication

CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a third medical condition, expanding the range of indications for the cannabis-derived medication. The orally administered drug from Britain’s GW Pharmaceuticals previously was approved by the FDA to treat seizures associated with two forms of severe epilepsy, Lennox-Gastaut […]

FDA approves GW Pharmaceuticals’ cannabis drug for new indication is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs



Source: FDA approves GW Pharmaceuticals’ cannabis drug for new indication


Tags

About the author

Steve Morrison

Steve Morrison

Steve serves as the founding editor of Hemp Stash News. With over 10 years experience in the news publishing business he decided to extend his vast portfolio by editing and publishing news about the Cannabis industry. Steve has a bachelor's degree in Journalism from the Northern Arizona University.

Steve can be reached out at: Steve.Morrison@hempstashnews.com

Add Comment

Click here to post a comment